Mucopolysaccharidosis VI [clinicaltrials_resource:7421f24829890c3976ca8f8d1b479d4d]
Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [clinicaltrials:NCT00005900]Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI [clinicaltrials:NCT00048620]Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VI [clinicaltrials:NCT00048711]Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI [clinicaltrials:NCT00067470]Study of rhASB in Patients With Mucopolysaccharidosis VI [clinicaltrials:NCT00104234]clinicaltrials:NCT00176917clinicaltrials:NCT00299000clinicaltrials:NCT00748969clinicaltrials:NCT01586455Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics [clinicaltrials:NCT01675674]Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease [clinicaltrials:NCT01707433]Mucopolysaccharidosis (MPS) I, II, and VI Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia in Combination With Pediatric ENT Surgery (The HATT Project) [clinicaltrials:NCT02095015]clinicaltrials:NCT02171104
condition [clinicaltrials_vocabulary:condition]
Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [clinicaltrials:NCT00005900]Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI [clinicaltrials:NCT00048620]Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VI [clinicaltrials:NCT00048711]Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI [clinicaltrials:NCT00067470]Study of rhASB in Patients With Mucopolysaccharidosis VI [clinicaltrials:NCT00104234]clinicaltrials:NCT00176917Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP) [clinicaltrials:NCT00214773]clinicaltrials:NCT00299000clinicaltrials:NCT00668564clinicaltrials:NCT00748969clinicaltrials:NCT01043640clinicaltrials:NCT01458613clinicaltrials:NCT01586455Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics [clinicaltrials:NCT01675674]Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease [clinicaltrials:NCT01707433]clinicaltrials:NCT01870375clinicaltrials:NCT01938014Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome A and Maroteaux-Lamy Syndrome [clinicaltrials:NCT01961518]Mucopolysaccharidosis (MPS) I, II, and VI Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia in Combination With Pediatric ENT Surgery (The HATT Project) [clinicaltrials:NCT02095015]Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome [clinicaltrials:NCT02156674]clinicaltrials:NCT02171104clinicaltrials:NCT02437253
condition browse [clinicaltrials_vocabulary:condition-browse]
Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [clinicaltrials:NCT00005900]Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI [clinicaltrials:NCT00048620]Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VI [clinicaltrials:NCT00048711]Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI [clinicaltrials:NCT00067470]Study of rhASB in Patients With Mucopolysaccharidosis VI [clinicaltrials:NCT00104234]clinicaltrials:NCT00176917Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP) [clinicaltrials:NCT00214773]clinicaltrials:NCT00299000clinicaltrials:NCT00668564clinicaltrials:NCT00748969clinicaltrials:NCT01043640clinicaltrials:NCT01458613clinicaltrials:NCT01586455Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics [clinicaltrials:NCT01675674]Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease [clinicaltrials:NCT01707433]clinicaltrials:NCT01870375clinicaltrials:NCT01938014Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome A and Maroteaux-Lamy Syndrome [clinicaltrials:NCT01961518]Mucopolysaccharidosis (MPS) I, II, and VI Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia in Combination With Pediatric ENT Surgery (The HATT Project) [clinicaltrials:NCT02095015]Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome [clinicaltrials:NCT02156674]clinicaltrials:NCT02171104clinicaltrials:NCT02437253
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Mucopolysaccharidosis VI [clinicaltrials_resource:7421f24829890c3976ca8f8d1b479d4d]
Bio2RDF identifier
7421f24829890c3976ca8f8d1b479d4d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7421f24829890c3976ca8f8d1b479d4d
identifier
clinicaltrials_resource:7421f24829890c3976ca8f8d1b479d4d
title
Mucopolysaccharidosis VI
@en
type
label
Mucopolysaccharidosis VI [clinicaltrials_resource:7421f24829890c3976ca8f8d1b479d4d]
@en
Mucopolysaccharidosis VI